New Key Statistics Module, Z-Score and F-Score
NAS:NKTR Key Ratios
Market Cap $ M | 248.51 |
Enterprise Value $ M | 89.37 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.12 |
Price/Sales | 2.84 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 93.00 |
EPS (TTM) $ | -0.90 |
Beneish M-Score | 5.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.59 |
EV-to-EBITDA | -0.61 |
PEG | -- |
Shares Outstanding M | 184.08 |
Net Margin (%) | -190.09 |
Operating Margin % | -145.03 |
Pre-tax Margin (%) | -190.17 |
Quick Ratio | 4.90 |
Current Ratio | 5.15 |
ROA % (ttm) | -42.69 |
ROE % (ttm) | -127.63 |
ROIC % (ttm) | -157.07 |
Dividend Yield % | -- |
Altman Z-Score | -14.34 |
NKTR Number of Guru Trades
NKTR Volume of Guru Trades
Gurus Latest Trades with NAS:NKTR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NKTR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nektar Therapeutics Insider Transactions
No Available Data
News about NAS:NKTR
Total 0- 1